
EMERGENT-5: Cobenfy and Treatment Durability
In this episode, we sit down with Dr. Oliver Freudenreich to unpack EMERGENT-5, the year-long trial tracking Cobenfy's real-world durability and safety in schizophrenia. We explore whether early symptom gains hold up over time, what side effects persist, and why blood pressure monitoring now deserves a permanent spot on your checklist. Faculty: Oliver Freudenreich, M.D., F.A.C.L.P. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.5 CME: Quick Take Vol. 85 Xanomeline-Trospium Long-Term: Does Efficacy and Safety Hold Up After One Year?
Publisher
Psychopharmacology and Psychiatry Updates
Link
psychopharmacology.libsyn.com/emergent-5-cobenfy-and-treatment-durability
Published
September 18, 2026
Duration
13 min
Format
Podcast
Category
Lifestyle · Medicine
Source
RSS feed
Host
Psychopharmacology Institute
Psychopharmacology and Psychiatry Updates
@psychopharmacologyandpsychia
#emergent #cobenfy #treatmentdurability #medicine
